Utah Medical Products, Inc. Reports Results of Tender Offer

The effective tender-offer cost was $75.36 per share, with another 1% federal excise tax to be levied on share repurchases.

Rhea-AI Summary

Utah Medical Products (UTMD) purchased 322,215 common shares through its tender offer, which expired on October 27, 2026.

The company offered to buy up to 650,000 shares at $75.00 per share and purchased shares for $24,166,125. Shares outstanding stood at 2,854,566 on October 29, including 1,775 employee option exercises in October.

1 point · 1 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 3 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major point$24,166,125 share repurchase completed through the purchase of 322,215 shares at $75.00 each. 11% of market cap

Negative

• Minor point$107,660 administration fees payable to Georgeson/Computershare and $6,732 in SEC filing fees add transaction costs.
• Minor point. Forward-looking: it has not happened yet and may not happen.Another 1% federal excise tax will be levied on share repurchases.
• Minor point1,775 employee option exercises in October added to outstanding shares.

News Explained

For the completed tender, UTMD reports $107,660 in administration fees and $6,732 in SEC filing fees, states an effective cost of $75.36 per share, and says a further 1% federal excise tax will be levied on share repurchases.

Key Figures

Tender offer limit and price: Up to 650,000 shares at $75.00 per share Shares purchased: 322,215 shares Purchase consideration: $24,166,125 +3 more

Tender offer limit and price

Up to 650,000 shares at $75.00 per share

Issuer tender offer

Shares purchased

322,215 shares

Tender offer results

Purchase consideration

$24,166,125

Paid for shares purchased

Effective cost

$75.36 per share

Effective tender offer cost

Shares outstanding

2,854,566 shares

After the tender offer; includes 1,775 October employee option exercises

Excise tax

1%

Tax levied on share repurchases

Historical Context

3 past events · Latest: Sep 15

3 events

1. Sep 15

   Self-tender announcement

   24h Move

   +5.6%

   Announced a tender offer for up to 650,000 shares at $75 per share.

2. Sep 24

   Tender offer commencement

   24h Move

   -0.8%

   Commenced the offer at $75 per share for up to 650,000 shares.

3. Oct 05

   Tender offer extension

   24h Move

   -1.1%

   Extended the offer deadline to October 27 without changing its terms.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

tender offer, excise tax

2 terms

tender offer financial

"The issuer Tender Offer expired Tuesday October 27."

A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.

View in glossary

excise tax financial

"Another 1% excise tax will be levied by the federal government"

An excise tax is a government charge levied on specific goods or activities—often applied per unit or as a percentage of price for items like fuel, tobacco, alcohol, or certain services—similar to a per-item toll added at the point of sale. It matters to investors because excise taxes raise costs for producers and consumers, can shrink profit margins or reduce demand, and therefore may affect a company’s revenues, pricing strategy and valuation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, UT / ACCESS Newswire / October 29, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) offered to purchase up to 650,000 shares of its common stock at $75.00 per share. The issuer Tender Offer expired Tuesday October 27.

In short, 322,215 shares were purchased for $24,166,125. Remaining UTMD shares outstanding at this date are 2,854,566 including 1,775 employee option exercises in October.

In addition, $107,660 administration fees will be paid to Georgeson/Computershare Inc., and $6,732 in filing fees to the SEC. The effective cost of the tender offer was 75.36/ share. Another 1% excise tax will be levied by the federal government on share repurchases.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.

Contact:

Brian Koopman
(801) 566-1200

SOURCE: Utah Medical Products, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were the results of Utah Medical Products' tender offer?

Utah Medical Products purchased 322,215 shares at $75.00 per share, totaling $24,166,125. The offer sought up to 650,000 shares and expired on October 27, 2026.

What was UTMD's effective tender-offer cost per share?

The effective tender-offer cost was $75.36 per share. Administration fees of $107,660 and SEC filing fees of $6,732 are payable. Another 1% federal excise tax will be levied on share repurchases.